Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology.
Times cited: 37
International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy.
Times cited: 116
Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder.
Journal of Urology.
Times cited: 120